bims-supasi Biomed News
on Sulfation pathways and signalling
Issue of 2026–11–15
ten papers selected by
Jonathan Wolf Mueller, University of Birmingham



  1. Infect Immun. 2026 Nov 10. e0055726
      To establish infection, uropathogens must overcome several host defenses, including the glycosaminoglycan (GAG) layer coating the apical surface of the bladder urothelium. GAGs are thought to protect against urinary tract infections (UTIs) by acting as a barrier to uropathogen adherence. However, the ability of uropathogens to degrade and utilize GAGs, and the contribution of these activities toward UTI progression, are largely unknown. We previously discovered that Proteus mirabilis, a common cause of catheter-associated UTI (CAUTI), degrades the GAG chondroitin sulfate (CS). In this study, we sought to define the kinetics and regulation of CS degradation by diverse urinary P. mirabilis strains. We found variation in CS degradation kinetics between P. mirabilis strains and media types. CS degradation in one isolate, Pm123, was repressed by urea, and this repression was dependent on P. mirabilis urease activity. Complementation of the Pm123 endolyase into urea-insensitive HI4320 resulted in a urea-sensitive CS degradation phenotype, suggesting functional differences between the Pm123 and HI4320 endolyases. Sequence alignment and structural modeling identified two unique mutations within the Pm123 endolyase that may contribute to urea sensitivity. Finally, unlike urea-insensitive P. mirabilis strains, loss of CS lyase activity had no effect on Pm123 virulence in a mouse CAUTI model. Our results suggest that the kinetics and regulation of CS degradation differ between P. mirabilis strains, and regulation by urea in some strains may reduce the contribution of CS degradation to urovirulence during murine CAUTI.
    Keywords:  chondroitin sulfate; glycosaminoglycan; proteus mirabilis; urinary tract infection
    DOI:  https://doi.org/10.1128/iai.00557-26
  2. Molecules. 2026 Oct 27. pii: 3868. [Epub ahead of print]31(21):
      Despite the widespread use of gelatin (Gel) in wound dressings due to its biocompatibility, biodegradability, and intrinsic bioactivity, it remains challenging to simultaneously achieve robust mechanical properties and multiple biofunctions in a single hydrogel system. Herein, we constructed a Gel/oxidized chondroitin sulfate (OCS) dynamic Schiff-base network and further introduced triglycidylamine (TGA) as a covalent crosslinker, yielding a Gel/OCS/TGA hydrogel with a proposed dynamic/covalent dual-crosslinked structure. Curcumin liposomes (Cur@Lipo), prepared using microfluidic technology, were then incorporated as bioactive nanofillers to obtain the multifunctional Gel/OCS/TGA/Cur@Lipo composite hydrogel. The hydrogel exhibited self-healing and injectable behavior, which may be associated with the reversible dynamic bonds present in the network. By adjusting the TGA content, the composite hydrogel achieved a tensile strength of 315 kPa, an elongation at break of 258%, and a compressive stress of 72 kPa at 60% strain. Moreover, the hydrogel exhibited sustained curcumin release, marked antioxidant activity (DPPH and ABTS radical scavenging rates of 59.8% and 83.98%, respectively), and antibacterial activity against E. coli and S. aureus (>99.99%), while maintaining good cytocompatibility. In summary, Gel/OCS/TGA/Cur@Lipo multifunctional composite hydrogel is a promising candidate for wound dressing applications, although further in vivo studies are required to confirm its clinical applicability.
    Keywords:  chondroitin sulfate; curcumin liposomes; dual-crosslinked hydrogel; gelatin; wound dressing
    DOI:  https://doi.org/10.3390/molecules31213868
  3. Cells. 2026 Oct 26. pii: 1946. [Epub ahead of print]15(21):
      Objective: Chronic kidney disease (CKD) worsens outcomes of peripheral artery diseases (PADs), partly through impaired vascular regeneration and microvascular remodeling. CKD promotes the accumulation of uremic toxins, but their contributions to microvascular dysfunction remain poorly understood. This study investigated the effects of uremic toxin indoxyl sulfate (IS) on vascular smooth muscle cell (VSMC) function and microvascular remodeling in a mouse model of CKD. Methods: C57BL6/J mice were fed 0.25% adenine diet for 10 days to induce CKD. CKD mice underwent hindlimb ligation surgery. VSMC migration assays, microscopy, and Western blotting were utilized to elucidate the underlying mechanisms underlying the IS-induced impairment of vascular remodeling. Results: CKD mice exhibited significantly impaired blood flow restoration (44.7% relative blood flow) compared with controls (82.6% relative blood flow) accompanied by a reduced α-smooth muscle expression and decreased formation of smooth muscle-covered micro vessels in ischemic limbs. Wound healing and transwell migrations assays demonstrated IS significantly reduced VSMC motility. IS-exposure also disrupted actin cytoskeletal organization, impaired cell attachment, reduced cell size, and decreased focal adhesion formation. Mechanistically, IS reduced focal adhesion kinase (FAK) expression, impairing VSMC adhesion and migration. Reduced FAK signaling was associated with decreased N-WASP expression and suppression of the Arp2/3 complex, which regulates actin polymerization and cytoskeletal remodeling. These alterations suggest that IS disrupts the cellular processes required for VSMC recruitment and structural remodeling of the microvascular, potentially limiting vessel maturation and stabilization during ischemic recovery. Conclusions: IS impairs VSMC migration and cytoskeletal organization through the disruption of the FAK-N-WASP-Arp2/3 signaling axis, contributing to defective microvascular remodeling and impaired perfusion recovery in CKD-associated PAD. These findings identify uremic toxin-mediated cytoskeletal dysfunction as a potential therapeutic target for improving microvascular regeneration and vascular recovery in patients with CKD.
    Keywords:  chronic kidney disease; focal adhesion kinase; indoxyl sulfate; microvascular remodeling
    DOI:  https://doi.org/10.3390/cells15211946
  4. J Phys Chem B. 2026 Nov 12. 130(45): 12054-12063
      Human endosulfatases HSulf-1 and HSulf-2 are the only extracellular sulfatases that selectively remove 6-O-sulfate groups from heparan sulfate chains, thereby regulating numerous signaling pathways involved in development, tissue homeostasis, and cancer. In particular, HSulf-2 is frequently overexpressed in human cancers, making it an attractive therapeutic target. However, its three-dimensional structure has not been resolved experimentally, mainly because of its multidomain organization, extensive post-translational modifications, and large intrinsically disordered hydrophilic domain (HD). Here, molecular dynamics simulations based on the AlphaFold2 model of HSulf-2 were used to investigate the structural and dynamic contributions of its domains and selected post-translational modifications. The simulations identified several intrinsically disordered regions, confirming that the HD constitutes the principal source of conformational disorder within the enzyme. They further demonstrate that the CAT-Cter assembly reproduces the canonical catalytic architecture conserved throughout the sulfatase family, whereas the HD induces only minor changes in the average structure while significantly destabilizing the conformational dynamics of the catalytic framework. In contrast, maturation of the catalytic residue modulates the conformational landscape of HSulf-2 without altering its overall architecture, whereas the conserved chitobiose cores of N-glycans exert only limited structural effects. These results support a modular structural organization in which the CAT-Cter assembly provides the conserved catalytic scaffold, while the HD confers the dynamic properties required for recognition of polymeric heparan sulfate substrates. This work provides a structural framework for understanding HSulf specificity and opens new perspectives for the rational design of selective HSulf inhibitors. In particular, the modular organization suggests that future dual-site inhibitors that simultaneously target the conserved catalytic pocket and the unique hydrophilic domain could combine high binding affinity with selectivity for HSulf enzymes.
    DOI:  https://doi.org/10.1021/acs.jpcb.6c04927
  5. J Med Invest. 2026 ;73(3.4): 438-449
      Indigo naturalis (IN), derived from the leaves of the indigo plant, is a traditional Chinese medicine that has historically been used for its anti-inflammatory properties in the treatment of various diseases, including ulcerative colitis (UC). However, long-term use of IN in UC is associated with the onset of pulmonary arterial hypertension. Our previous study showed that chronic administration of the raw material of IN, indigo leaves (IL), induced medial thickening in pulmonary arteries accompanied by pulmonary endothelial cell (EC)-derived endothelin-1 (ET-1) induction in rats and suggested that a major component of IL, indican, and its metabolite, indoxyl sulfate (IS), induced ET-1 expression in an aryl hydrocarbon receptor (AhR)-independent manner in ECs as a key mechanism for vascular remodeling. In this study, indican and IS were found to induce EC senescence in an AhR-dependent manner, and RNA-seq analysis and western blotting demonstrated that indican had stronger AhR activation-dependent DNA damage activity than IS in ECs. Furthermore, pulmonary EC-derived DNA damage was confirmed to occur in IL-treated rats without impaired liver function. Thus, this study identified unique roles for indican in EC senescence and DNA damage, which contributed to pulmonary arterial remodeling through AhR activation. J. Med. Invest. 73 : 438-449, August, 2026.
    Keywords:  Aryl hydrocarbon receptor; Indican; Indigo leaves; Indoxyl sulfate; Pulmonary arterial hypertension
    DOI:  https://doi.org/10.2152/jmi.73.438
  6. Int J Mol Sci. 2026 Oct 30. pii: 9754. [Epub ahead of print]27(21):
      The high physiological activity of steroid hormones requires multilevel regulation of their biosynthesis. Cytosolic sulfotransferases, specifically SULT2A1 and SULT1E1, convert steroid precursors into mobile sulfated depot forms, diverting them from key steroidogenic cytochromes P450. Given the previously demonstrated CYP17A1-SULT interactions, this study aims to verify the hypothesis that CYP21A2 can interact with SULTs and thereby potentially contribute to the regulation of steroid metabolism. Using surface plasmon resonance (SPR) biosensing, in vitro enzymatic activity assays, and in silico molecular modeling, we investigated the interplay between CYP21A2 and SULT2A1/1E1. SPR analysis revealed high-affinity binding between purified recombinant CYP21A2 and SULT2A1/SULT1E1 in vitro in the nanomolar range (9.5 × 10-9 M for SULT2A1 and 1.15 × 10-8 M for SULT1E1). Thermodynamic assessments indicated that the CYP21A2-SULT1E1 complex is entropy-driven, contrasting with the enthalpy-driven CYP17A1-SULT1E1 interaction. Enzymatic assays demonstrated reciprocal modulatory effects: CYP21A2 exerted a stimulatory effect on pregnenolone sulfation by SULTs, whereas SULT2A1 moderately inhibited CYP21A2 activity. Molecular modeling of binary complexes predicted structural interfaces and continuous intraprotein channels connecting the enzymes' active sites. These findings suggest that CYP-SULT interactions may contribute to the fine-tuning of steroid hormone biosynthesis. These findings raise the possibility that CYP-SULT interactions may form part of a broader regulatory network, acting as metabolic switches that dictate the balance between downstream corticosteroid pathways and structural sequestration into sulfated pools.
    Keywords:  CYP21A2; SULT1E1; SULT2A1; enzymatic activity modulation; molecular modeling; protein–protein interactions; steroid hormone biosynthesis; surface plasmon resonance
    DOI:  https://doi.org/10.3390/ijms27219754
  7. Sci Rep. 2026 ;16 29870
      Inter-individual variability in (poly)phenol metabolism can significantly influence health effects, yet its mechanisms are poorly understood. Through a validated multi-tiered computational workflow, this study explored how a single nucleotide polymorphism (SNP) in the SULT1A1 gene (SULT1A1-F247L, forming SULT1A1*5 allozyme) might influence the sulfation of 20 dietary (poly)phenols. The methodological approach combined molecular docking and molecular dynamics simulations, monitoring hydroxy group orientation toward the PAPS cofactor sulfate - an essential requirement for efficient sulfation. Among the (poly)phenols examined, several compounds were stably recruited by both allozymes, suggesting limited polymorphism effects on their sulfation. Conversely, SNP-specific sulfation preferences were recorded for daidzein, isourolithin A, and various γ-valerolactone derivatives. This study shows how SNPs may selectively influence metabolic fates of specific (poly)phenols regardless of chemical subclasses, providing a valuable proof-of-principle addressing the variability of their metabolism among humans. This methodology provides a basis for understanding the mechanisms underlying inter-individual variability, explaining individual responses to (poly)phenol-rich foods.
    Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1038/s41598-026-65193-1.
    Keywords:  (poly)phenols; Inter-individual variability; Molecular modelling; Single-nucleotide polymorphisms; Sulfotransferase 1A1
    DOI:  https://doi.org/10.1038/s41598-026-65193-1
  8. Cells. 2026 Oct 30. pii: 1985. [Epub ahead of print]15(21):
      Protein tyrosine sulfation (PTS), an important post-translational modification (PTM), has garnered increasing attention in life sciences in recent years. Following classical and emerging PTMs such as phosphorylation, lactylation, acetylation, and palmitoylation, PTS has now emerged as a novel entry point in disease mechanistic studies. As an evolutionarily conserved modification ubiquitously present in organisms, PTS acts as a core molecular switch that modulates fundamental biological processes via specific conjugation of sulfate groups to tyrosine residues of target proteins. Accumulating evidence has revealed that PTS modifies numerous pivotal functional proteins, such as chemokine receptors, histones, and coagulation factors, and participates in multiple physiological and pathological events, including hormonal modulation, gene transcription, hemostasis, inflammatory responses, cancer progression, and viral infection. Consequently, deeper insight into the mechanisms of PTS and its targeted intervention holds promise for novel therapeutic strategies for related diseases. Nevertheless, the molecular regulatory network of PTS remains poorly understood, which is largely attributed to the limitations of current techniques for the efficient preparation and accurate detection of PTS-modified proteins. This review systematically summarizes the latest advances in the biological functions and regulatory mechanisms of PTS, aiming to provide a theoretical reference for subsequent fundamental research and offer potential therapeutic targets for the clinical treatment of PTS-related diseases.
    Keywords:  biological functions; post-translational modification; protein tyrosine sulfation; regulatory mechanisms; therapeutic targets
    DOI:  https://doi.org/10.3390/cells15211985
  9. Food Funct. 2026 Nov 09.
      Previous studies have demonstrated that sulfated fucans from Saccharina japonica (SJ-FUC) promote intestinal epithelial development in juvenile mice. However, whether this biofunctionality depends on the gut microbiota and which microbial responders contribute to this process remain unclear. Here, we integrated in vitro anaerobic fermentation, metagenomic analysis, antibiotic-mediated microbiota depletion, bacterial isolation, and juvenile mouse intervention to investigate the microbial basis underlying the intestinal biofunctionality of SJ-FUC. In vitro fecal fermentation showed that SJ-FUC markedly remodeled the gut microbiota derived from both conventional and SJ-FUC-adapted mice and selectively enriched specific bacterial taxa. Limosilactobacillus reuteri exhibited a consistent response to SJ-FUC, with a higher baseline abundance in adapted microbiota and further enrichment after fermentation. In antibiotic-treated mice, microbiota depletion markedly attenuated SJ-FUC-induced intestinal stem cell-associated responses, epithelial proliferation, and secretory lineage differentiation, demonstrating that the intestinal effects of SJ-FUC are largely microbiota-dependent. A strain of L. reuteri, designated L11, was subsequently isolated from the SJ-FUC fecal fermentation system and functionally evaluated in juvenile mice. Both viable L11 and its cell-free supernatant upregulated the intestinal stem cell markers Lgr5, Olfm4, and Ascl2, enhanced Wnt/β-catenin-related gene expression and epithelial proliferation, and promoted secretory lineage differentiation. Overall, these findings establish the gut microbiota as an important contributor to the intestinal biofunctionality of SJ-FUC and identify L. reuteri L11 as a functional microbial responder associated with these effects. This study provides new insight into how an edible-algae-derived sulfated polysaccharide influences juvenile intestinal epithelial development through interactions with the gut microbiota.
    DOI:  https://doi.org/10.1039/d6fo04530h
  10. PNAS Nexus. 2026 Nov;5(11): pgag340
      Long-term intake of a high-fat diet (HFD) induces gut microbiota dysbiosis associated with inflammation and is linked to metabolic abnormalities and depressive-like behaviors. The soluble form of sialic acid-binding Ig-like lectin-9 (s-Siglec-9) exhibits therapeutic effects against inflammatory diseases, and exercise is known to have antidepressant effects. However, the effects of s-Siglec-9 on HFD-induced depressive-like behaviors, alone or in combination with exercise, remain unclear. In this study, we investigated the therapeutic effects of s-Siglec-9 combined with exercise in mice with HFD-induced metabolic dysfunction. Mice were fed an HFD ad libitum for 8 weeks, and interventions were conducted during the final 4 weeks. The induction of the anti-inflammatory phenotype by s-Siglec-9 was also investigated using primary microglia. The results revealed significant suppression of depressive-like behaviors in the intervention groups compared with the group fed only the HFD, with the effect being greater in the s-Siglec-9 with exercise group. Histological analyses showed reduced microglial activation and astrogliosis in the hippocampus and hypothalamus, together with increased hippocampal neurogenesis. Gut microbiota analysis showed a decrease in inflammatory bacterial genera and an increase in short-chain fatty acid-producing bacterial genera in the intervention groups. In vitro, s-Siglec-9 promoted a shift in primary microglia toward an anti-inflammatory and neurotrophic M2-like state in the presence of monocyte chemoattractant protein-1 and chondroitin sulfate proteoglycans. Our study suggests the potential of combining administration of an anti-inflammatory substance with exercise as a therapeutic strategy for metabolic abnormalities accompanied by depressive-like behaviors, potentially involving coordinated changes across gut microbiota, inflammatory, and neural systems.
    Keywords:  depressive-like behaviors; exercise; gut–brain axis; metabolic abnormalities; soluble Siglec-9
    DOI:  https://doi.org/10.1093/pnasnexus/pgag340